General News

Nuclear Medicine Radioisotopes Market 2019 Current Status, Recent Developments, Significant Growth Rate, Cost Structure, and Forecast till 2024

Nuclear Medicine Radioisotopes

The “Nuclear Medicine Radioisotopes Market” Report 2019-2024 has adopted a systematic way to evaluate the dynamics of the overall market. Nuclear Medicine Radioisotopes Market reports offers detailed assessment of the Nuclear Medicine Radioisotopes including enabling technologies, key trends, market drivers, challenges, market landscape, opportunities and competitor strategies.

Ask for Sample PDF of Nuclear Medicine Radioisotopes Market Report @ https://www.industryresearch.co/enquiry/request-sample/13999554

Market Overview:

  • Increasing cases of cancer and cardiac ailments are the major drivers for the nuclear medicines radioisotopes market. Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics. They meet the statutory definition of drugs under Section 1861(t) of the Social Security Act because they either are included in the various drug compendia or recognized by hospital medical staff as drugs. Historically, nuclear medicine has been well established as a therapeutic modality for thyroid cancer, Graves’ disease, hyperthyroidism, and bone pain palliation, associated with skeletal metastasis. Hence, the broadening applications of radioisotopes are expected to propel market growth.

    Nuclear Medicine Radioisotopes Market Covers the Following Manufacturers:

  • Agfa
  • Gevaert Group
  • Cardiarc Ltd
  • Digirad Corporation
  • CMR Naviscan (Gamma Medica Inc.)
  • GE Healthcare
  • Positron Corp.
  • Segami Corporation
  • Siemens Healthcare GmBH
  • Nordion (Canada) Inc.
  • NTP Radioisotopes SOC Ltd
  • Bracco S.p.A
  • Cardinal Health Inc.
  • Curium

    Have Any Query? Ask Our Industry Experts @ https://www.industryresearch.co/enquiry/pre-order-enquiry/13999554

    Key Market Trends:

    Oncology Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

    Radiotherapy can be used to treat various medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. PET, which is a precise technique, uses isotopes produced in a cyclotron. It is highly used for a clinical role in oncology, with fluorine-18 as the tracer, and is proven to be the most accurate non-invasive method of detecting and evaluating most cancers. A new field for cancer treatment is targeted alpha therapy (TAT) or alpha radio-immunotherapy, especially for the control of dispersed cancers. Nuclear medicine is proven effective in oncology in several roles, spanning the course of the disease, including the characterization of a mass, staging, restaging, and monitoring of therapeutic response. Hence, owing to these associated factors, the oncology segment is expected to exhibit the fastest growth rate.

    North America captured the Largest Market Share and is Expected to Retain its Dominance

    North America captured the largest market share in the nuclear medicine radioisotopes market. The United States was the largest contributor to the revenue of North America, and is expected to retain its dominance owing to the higher procedural volume and increasing adoption of the nuclear medicine isotopes for various therapeutic applications. Bone scintigraphy is the next most common nuclear medicine procedure performed in the United States, but it represents only 17% of procedures. The volume of PET procedures in the United States is approximately 1.5 million per year. Oncology accounts for more than 90% of the PET and PET/CT procedures performed, whereas cardiology and neurology account for about 4% each. Canada is the largest producer of Technetium-99m. Due to the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. 80% of the nuclear medicine market is driven by Tc-99m in various diagnostic procedures and treatments. Considering these factors associated with the United States and Canada, the North American market is expected to experience accelerated growth rates and market dominance.

    Ask For Discount @ https://www.industryresearch.co/enquiry/request-discount/13999554

    Scope of the Report:

  • As per the , medical radioisotopes are defined as safe radioactive substances that are primarily used in the diagnosis of medical conditions. These radioisotopes, used in a diagnosis, emit gamma rays of energy that are sufficient to escape from the body. The rays also have a short half-life, which is apt, since the rays can decay as soon as the imaging is completed.

    Important Points Covered in Nuclear Medicine Radioisotopes Market Report:

    • Nuclear Medicine Radioisotopes market gives assessments for the regional level analysis with Production, Consumption, Imports, and Exports.
    • Nuclear Medicine Radioisotopes market forecasts for a minimum of five years of all the mentioned segments.
    • Nuclear Medicine Radioisotopes market shares drivers, constraints, opportunities, threats, challenges, investment opportunities.
    • Share constraints for the new entrants in Nuclear Medicine Radioisotopes market
    • Include manufacturing process, suppliers, price, production and consumption analysis.

    This report covers the following questions:

    • What are the difficulties to showcase development?
    • What will the market estimate be in 2024 and what will the improvement rate be?
    • Who are the major key venders in this market space?
    • What are the drivers and opportunities of Nuclear Medicine Radioisotopes market?

    Price of Report: $ 4250 (Single User License)

    Purchase Nuclear Medicine Radioisotopes Market Report @ https://www.industryresearch.co/purchase/13999554

    Nuclear Medicine Radioisotopes Market Covers Following Points in TOC:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Incidences of Cancer and Cardiac Disorders
    4.2.2 Widening Applications of Nuclear Medicine
    4.2.3 Increasing SPECT and PET Applications
    4.2.4 Increasing Patient Awareness for Healthcare
    4.3 Market Restraints
    4.3.1 Reimbursement Complications
    4.3.2 Regulatory Issues
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Type of Radioisotopes
    5.1.1 Technetium-99m (Tc-99m)
    5.1.2 Thallium-201 (Tl-201)
    5.1.3 Iodine (I-123)
    5.1.4 Fluorine-18
    5.1.5 Rubidium-82 (Rb-82)
    5.1.6 Iodine-131 (I-131)
    5.1.7 Lutetium-177 (Lu-177)
    5.1.8 Radium-223 (Ra-223) & Alpharadin
    5.1.9 Actinium-225 (Ac-225)
    5.1.10 Others
    5.2 Application
    5.2.1 Oncology
    5.2.2 Cardiology
    5.2.3 Lymphoma
    5.2.4 Thyroid
    5.2.5 Neurology
    5.2.6 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Rest of the World

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Agfa-Gevaert Group
    6.1.2 Cardiarc Ltd
    6.1.3 Digirad Corporation
    6.1.4 CMR Naviscan (Gamma Medica Inc.)
    6.1.5 GE Healthcare
    6.1.6 Positron Corp.
    6.1.7 Segami Corporation
    6.1.8 Siemens Healthcare GmBH
    6.1.9 Nordion (Canada) Inc.
    6.1.10 NTP Radioisotopes SOC Ltd
    6.1.11 Bracco S.p.A
    6.1.12 Cardinal Health Inc.
    6.1.13 Curium

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: sales@industryresearch.co

    Our latest Report: Hyperloop Technology Market 2019 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2024